Lv5
1000 积分 2024-09-05 加入
Clinical effectiveness of surgical treatment after lenvatinib administration for hepatocellular carcinoma
1个月前
已完结
Immune checkpoint inhibitor-related T-cell-mediated rejection increases the risk of perioperative graft loss after liver transplantation
3个月前
已关闭
Transarterial Yttrium-90 Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis
4个月前
已完结
Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma
4个月前
已完结
Chemoradiotherapy for Initially Unresectable Locally Advanced Cholangiocarcinoma
4个月前
已完结
Improved oncologic outcome with chemoradiotherapy followed by surgery in unresectable intrahepatic cholangiocarcinoma
4个月前
已完结
Intrahepatic cholangiocarcinoma: Evolving strategies in management and treatment
6个月前
已完结
Surgical Resection Does Not Improve Survival in Multifocal Intrahepatic Cholangiocarcinoma: A Comparison of Surgical Resection with Intra-Arterial Therapies
6个月前
已完结
Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial
6个月前
已完结
Hepatic arterial infusion of GEMOX plus systemic gemcitabine chemotherapy combined with lenvatinib and PD-1 inhibitor in large unresectable intrahepatic cholangiocarcinoma
6个月前
已完结
皖公网安备34019202002308
